Andreas Saltos

5PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 12, 2025
Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non-Small Cell Lung Cancer.

Brian D Gonzalez, Xiaoyin Li, Lisa M Gudenkauf

|Feb 24, 2025
Reply to: Osimertinib Plus Antiangiogenic Agents: A Promising New Paradigm With Uncertain Results.

Xiuning Le, Mike Hernandez, Simon Heeke

|Oct 08, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve <i>EGFR</i>-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial).

Xiuning Le, Jyoti D Patel, Elaine Shum

|Jul 01, 2021
Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.

Dung-Tsa Chen, Wenyaw Chan, Zachary J Thompson

Pageof 1